		<div class="wpcnt">
			<div class="wpa">
				<span class="wpa-about">Advertisements</span>
				<div class="u top_amp">
							<amp-ad width="300" height="265"
		 type="pubmine"
		 data-siteid="111265417"
		 data-section="1">
		</amp-ad>
				</div>
			</div>
		</div><p>Pharmaceutical giant AstraZeneca is to buy US drug developer Alexion in a deal worth almost £30 billion.</p>
<p>Cambridge-based AstraZeneca, which is developing a Covid-19 vaccine, said on Saturday it is using a combination of cash and shares for the acquisition of Boston-based Alexion Pharmaceuticals.</p>
<p>The boards of both companies have unanimously approved the transaction, but it still needs regulatory and shareholder approval.</p>
<p>The deal is expected to close in the third quarter of 2021.</p>
<p>AstraZeneca chief executive Pascal Soriot said: “This acquisition allows us to enhance our presence in immunology.”</p>
<p>The company and Oxford University have jointly developed a coronavirus vaccine that British and Canadian regulators are assessing.</p>
			<div style="padding-bottom:15px;" class="wordads-tag" data-slot-type="belowpost">
				<div id="atatags-dynamic-belowpost-69022bb796802">
					<script type="text/javascript">
						window.getAdSnippetCallback = function () {
							if ( false === ( window.isWatlV1 ?? false ) ) {
								// Use Aditude scripts.
								window.tudeMappings = window.tudeMappings || [];
								window.tudeMappings.push( {
									divId: 'atatags-dynamic-belowpost-69022bb796802',
									format: 'belowpost',
								} );
							}
						}

						if ( document.readyState === 'loading' ) {
							document.addEventListener( 'DOMContentLoaded', window.getAdSnippetCallback );
						} else {
							window.getAdSnippetCallback();
						}
					</script>
				</div>
			</div>
Discover more from London Glossy Post
Subscribe to get the latest posts sent to your email.
